Trial Profile
Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Dec 2019
Price :
$35
*
At a glance
- Drugs Sodium fytate (Primary)
- Indications Calciphylaxis
- Focus Proof of concept; Therapeutic Use
- Sponsors Laboratoris Sanifit
- 25 May 2018 According to a Laboratoris Sanifit S.L. media release, results from this trial will be presented at the 55th ERA-EDTA Congress, Copenhagen, Denmark (from 24th-27th May 2018).
- 25 May 2018 Results published in a Laboratoris Sanifit S.L. media release.
- 06 Mar 2018 Primary endpoint (Wound Healing:Assessment of lesion score using Bates-Jensen wound assessment tool) has been met, according to a Sanifit media release.